Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
about
Alteration of estrogen-regulated gene expression in human cells induced by the agricultural and horticultural herbicide glyphosateDuffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibilityPotent antiviral synergy between monoclonal antibody and small-molecule CCR5 inhibitors of human immunodeficiency virus type 1Association studies for asthma and atopic diseases: a comprehensive review of the literatureAssociation study of functional genetic variants of innate immunity related genes in celiac disease.Genetic correlates influencing immunopathogenesis of HIV infectionGenetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorderHIV and the chemokine system: 10 years later.Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogsGlobal survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.The longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning.The role of host genetics in the susceptibility for HIV-associated neurocognitive disorders.Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosusGenetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer.Concordance of functional in vitro data and epidemiological associations in complex disease genetics.A genetic association study of CCL5 -28 C>G (rs2280788) polymorphism with risk of tuberculosis: a meta-analysis.The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing ChineseCCL5 regulation of mucosal chlamydial immunity and infection.Gene expression variability within and between human populations and implications toward disease susceptibility.Effect of RANTES gene promoter genotypes in patients with ulcerative colitis.Chemokines and asthma: redundancy of function or a coordinated effort?Host genetics influences on HIV type-1 disease.Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype.Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5.Role of chemokine and cytokine polymorphisms in the progression of HIV-1 disease.Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants.Effect of host genetics on incidence of HIV neuroretinal disorder in patients with AIDS.Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progressionRole of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with pneumocystis pneumonia.CCL3 genotype and current depression increase risk of HIV-associated dementiaModulating influence on HIV/AIDS by interacting RANTES gene variantsEffect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS.Chemokines and their receptors in infectious disease.HIV-1 disease progression is associated with bile-salt stimulated lipase (BSSL) gene polymorphism.Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infection.Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection.Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication.Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.RANTES gene G-403A polymorphism and coronary artery disease: a meta analysis of observational studies.Association between regulated upon activation, normal T cells expressed and secreted (RANTES) -28C/G polymorphism and susceptibility to HIV-1 infection: a meta-analysis.
P2860
Q23919770-4F2951E3-2C14-4FC8-8288-B1CF7CDAE644Q24657233-480657C6-7E90-479E-B69D-A5C9C846AD74Q24673555-C70F3FA5-7C36-4BA6-931A-E01C58753569Q24802474-5F238872-8200-4740-9B90-7F2D089DB3FDQ24815440-71EEED20-7934-4B99-858C-3334C14EAF62Q26827459-FACC9352-DEFE-4DD0-A77A-FA6039766C8FQ26865707-8753A8B0-10F5-453C-AC31-941FBE8A3431Q27473020-5653DB1B-B0B8-4928-9146-FDB01FBFFA4EQ28344169-7096EB61-46CA-4C35-A944-EE1F6BC25FB8Q30328141-63CD1154-8313-45C2-B4E6-709D33A18F83Q30410418-E5ED4AF6-53A4-48DA-9FD5-B2E112E50CFCQ30411844-1C5E1E1B-B607-496C-B2A6-043695509647Q30815929-60E38E65-EB83-46BF-8DD9-D0D215C4130FQ30855755-C64267FC-A9CC-4759-96DA-93FB2A4BF4C4Q31061331-455D3622-A6FF-478A-A445-8910C5F480C4Q31146796-1DC747E0-9502-44DA-BF9B-438C19A66DD5Q33286334-C7397372-CB2D-4D8A-B3DA-D73648E46AAAQ33359789-F8816F46-D4FA-4EA5-AB9F-472DFE0A6ABBQ33701750-FA93A04F-4CF2-404C-A852-6C9DE308E2FBQ33733566-BE0B895D-51D7-403D-ADD7-33994B544955Q33753439-D361895F-421A-4311-AFE4-4441B5F324EEQ33775595-52860CA6-EA26-4E29-8D7A-BD8DFBE622DDQ33805434-B3041AD7-06E1-40CF-908A-4E6501EC8E35Q33838860-D37C69D3-5BAD-4FE4-8261-C7944A6E11C7Q33964392-CAFA1FC2-1BC3-4DA6-97D5-C0472192C44EQ33990311-DD44BB15-6752-4D65-B3E5-5100315AAC83Q34014864-392C7912-80D3-49B2-BAF0-0A50B171C8B0Q34045563-F5E01BB1-ABB0-4E0B-AFE1-9289DB8483EAQ34064248-AABBBD63-E144-4E4E-B87A-DF0D52F3F332Q34072394-05F6056F-DEDC-4C84-860C-49D231559A29Q34098634-64F4E72A-BB54-4502-A62B-8F396CC53C8FQ34101540-5D05A1C9-9806-4E3D-984A-EC6EDDAB374FQ34129756-44BB315F-342C-422B-9CD3-7E26FF20735DQ34193190-CB7D76C4-17ED-4C8F-8891-BB1EEDDD2D31Q34227596-BEC4FCF2-D57A-4579-873B-F6BEB3933CB7Q34255654-9B6427B0-F0D1-4510-B1B3-F27DC5482021Q34339609-884A4BCC-05CB-41A6-8500-1A4C15DFC26AQ34357979-F3958A03-B145-4EB9-B943-D039DD3B4813Q34448063-E65CDC26-53BA-44F1-9699-F15D08191622Q34663921-92AF4B4D-175A-4199-9678-CCC96376DEE1
P2860
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
@ast
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
@en
type
label
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
@ast
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
@en
prefLabel
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
@ast
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
@en
P2093
P2860
P356
P1476
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
@en
P2093
Fukutake K
Ishikawa Y
Maruyama Y
P2860
P304
P356
10.1073/PNAS.96.8.4581
P407
P577
1999-04-01T00:00:00Z